Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Taylor AJ Jr (1994) Strontium-89 for the palliation of bone pain due to metastatic disease. J Nucl Med 35:2054
2. Annex 1: Evaluation of pain WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. World Health Organization https://apps.who.int › handle › 9789241550390-eng Accessed Nov 13th 2021
3. Common Terminology Criteria for Adverse Events (CTCAE) v5. National cancer institute https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm Accessed Nov 13th 2021
4. Chow E, Hoskin P, Mitera G et al (2012) Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Int J Radiat Oncol Biol Phys 82:1730–1737. https://doi.org/10.1016/j.ijrobp.2011.02.008
5. Furubayashi N, Negishi T, Ura S et al (2015) Palliative effects and adverse events of strontium-89 for prostate cancer patients with bone metastasis. Mol Clin Oncol 3:257–263. https://doi.org/10.3892/mco.2014.449
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献